<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>408</id><JournalTitle>DIAGNOSIS AND PHARMACOTHERAPY OF GLAUCOMA: RECENT TRENDS</JournalTitle><Abstract>Glaucoma is a term describing a group of ocular (eye) disorders that result in optic nerve damage, often associated
with increased fluid pressure in the eye (intraocular pressure) (IOP). The disorders can be roughly divided into two main
categories, "open-angle" and "closed-angle" (or "angle closure") glaucoma. Open-angle chronic glaucoma is painless, tends
to develop slowly over time and often has no symptoms until the disease has progressed significantly. It is treated with
either glaucoma medication to lower the pressure, or with various pressure-reducing glaucoma surgeries. Closedangle glaucoma, however, is characterized by sudden eye pain, redness, nausea and vomiting, and other symptoms resulting
from a sudden spike in intraocular pressure, and is treated as a medical emergency. Glaucoma can permanently damage
vision in the affected eye(s), first by decreasing peripheral vision (reducing the visual field), and then potentially leading
to blindness if left untreated. Pharmacotherapy is mainly available for open angle glaucoma. Here we will focus on recent
development in pharmacotherapy of Glaucoma.</Abstract><Email>dendoctor5@gmail.com</Email><articletype>Review</articletype><volume>5</volume><issue>12</issue><year>2015</year><keyword>Glaucoma,Open-angle,Closed-angle,Pharmacotherapy</keyword><AUTHORS>Dhone PG,Singh P,Gupta SB</AUTHORS><afflication> Associate Professor, Department of Pharmacology ,Associate Professor,L.N. Medical College and Research Centre, Bhopal, Madhya Pradesh, India.,Dean & Professor & Head, Department of Ophthalmology, L.N. Medical College and Research Centre, Bhopal, Madhya Pradesh, India.</afflication></Article></Articles>